Amyvid
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Insufficient evidence proving benefit of Alzheimer’s drug Amyvid behind Medicare’s ruling to limit or deny coverage.
FDA has approved florbetapir F 18 injection, or Amyvid, for imaging amyloid plaques in adults whose cognitive impairment may be…